Loading
Latest filing published 02 Jan 2025 for Mallinckrodt plc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Peter C. Richardson across 2 companies, led by Mallinckrodt plc and Antares Pharma, Inc. Between 10 June 2021 and 1 January 2025, the trades on record add up to 5 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 2 January 2025 came the latest disclosure, an option exercise in Mallinckrodt plc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations